ID: h-SDA-2026-04-26-gap-debate-20260426-011
Hypothesis

Circulating Endothelial Microvesicles Expressing Degraded Claudin-5 as Specific Markers of Early BBB Permeability

Endothelial cells shed microvesicles (EMVs) during activation or injury.
🧬 CLDN5 fragments on CD31+/CD144+ EMVs🎯 Composite 64%💱 $0.61▼6.1%proposed
neurodegeneration
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.74 (15%) Evidence 0.52 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.640 composite

🧪 Overview

Endothelial cells shed microvesicles (EMVs) during activation or injury. EMVs from degenerating brain endothelium carry fragments of tight junction proteins (particularly degraded claudin-5), which can be immunoprecipitated from blood and quantified. These EMV-associated junction fragments specifically reflect BBB-derived permeability rather than peripheral vascular leakiness. Technical validation remains a significant challenge.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["CD31+/CD144+<br/>Endothelial Microvesicles"]
    B["CLDN5 Fragments<br/>on EMV Surface"]
    C["EMV-Mediated<br/>Signaling"]
    D["Microvascular<br/>Endothelial Activation"]
    E["Pericyte<br/>Dysfunction"]
    F["BBB<br/>Compromise"]
    G["Neuroinflammation<br/>Progression"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
EMVs bearing tight junction proteins increase in AD plasma
Supports
EMV cargo reflects brain-specific endothelial injury using in vitro BBB models
Supports
EMV claudin-5 as marker of cerebrovascular disease
Contradicts
EMV isolation and characterization methodology not standardized across studies
Contradicts
Distinguishing brain-derived EMVs from peripheral vascular EMVs remains technically challenging
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CLDN5

No curated PDB or AlphaFold mapping for CLDN5 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for CLDN5 fragments on CD31+/CD144+ EMVs from GTEx v10.

Spinal cord cervical c-169.0 Substantia nigra65.1 Hippocampus53.0 Hypothalamus50.9 Putamen basal ganglia50.5 Cortex50.3 Caudate basal ganglia45.5 Frontal Cortex BA941.4 Amygdala38.4 Cerebellum35.5 Anterior cingulate cortex BA2435.2median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CLDN5 fragments on CD31+ →

No DepMap CRISPR Chronos data found for CLDN5 fragments on CD31+.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0087
Events (7d)
1
Price History
▼6.1%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If circulating endothelial microvesicles (EMVs) expressing degraded claudin-5 (CLDN5 fragments on CD31+/CD144+ EMVs) are a specific biomarker of paracellular BBB degradation, then CLDN5 fragment+ EMVsEMV analysis by flow cytometry (CD31+CD144+ CLDN5 fragment+) in stratified cohorts shows: elevated CLDN5 fragment+ EMVs in paracellular dysfunction (TBI, n≥40, — no observation —pending0.73
🔮 Falsifiable Predictions (1)
pendingconf —
If circulating endothelial microvesicles (EMVs) expressing degraded claudin-5 (CLDN5 fragments on CD31+/CD144+ EMVs) are a specific biomarker of paracellular BBB degradation, then CLDN5 fragment+ EMVs will be elevated in paracellular BBB dysfunction (TBI, stroke) but not in transcytosis dysfunction
Predicted outcome: EMV analysis by flow cytometry (CD31+CD144+ CLDN5 fragment+) in stratified cohorts shows: elevated CLDN5 fragment+ EMVs in paracellular dysfunction (T
Falsification: CLDN5 fragment+ EMVs are elevated across all BBB dysfunction types regardless of mechanism; no specificity to paracellular vs transcytosis dysfunction; no correlation with Qalb or MRI leakage, indicat
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.